Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
Clinical trial NCT00604175 · COMPLETED
Trial details
- NCT number
- NCT00604175
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2012-01-01
- Enrollment
- 319
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.